1. Home
  2. RVT vs ANIP Comparison

RVT vs ANIP Comparison

Compare RVT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Royce Value Trust Inc.

RVT

Royce Value Trust Inc.

N/A

Current Price

$16.71

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

N/A

Current Price

$67.86

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVT
ANIP
Founded
1986
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
RVT
ANIP
Price
$16.71
$67.86
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $105.78
AVG Volume (30 Days)
250.8K
★ 310.9K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 7.32%
N/A
EPS Growth
N/A
★ 419.23
EPS
2.95
★ 3.86
Revenue
N/A
★ $206,547,000.00
Revenue This Year
N/A
$24.85
Revenue Next Year
N/A
$10.76
P/E Ratio
★ $5.82
$18.56
Revenue Growth
N/A
★ 2.47
52 Week Low
$14.97
$69.58
52 Week High
$19.12
$90.87

Technical Indicators

Market Signals
Indicator
RVT
ANIP
Relative Strength Index (RSI) 44.74 37.70
Support Level $15.84 N/A
Resistance Level $18.63 $83.03
Average True Range (ATR) 0.28 2.34
MACD 0.04 -0.27
Stochastic Oscillator 27.96 1.20

Price Performance

Historical Comparison
RVT
ANIP

About RVT Royce Value Trust Inc.

Royce Small-Cap Trust Inc is a diversified closed-end investment company that invests in equity securities of small-cap companies. The company portfolio includes sectors such as Industrials, Financials, Information Technology, Health Care, and Consumer Discretionary.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: